Alfredo Pascual headshot
EMAIL: [email protected]
PHONE: 720.213.5971

Alfredo Pascual

Based in Germany, Alfredo specializes in international cannabis markets and regulations. He has an academic background in business and public policy and founded Transnational Cannabis, a consultancy firm that focused on cannabis regulatory frameworks in Europe and Latin America. Previously, he did business development for ICC Labs with a primary focus on developing expansion opportunities internationally.


Luxembourg’s medical cannabis program continues rapid implementation

Luxembourg’s medical marijuana program – approved in June 2018 – continues its fast-paced implementation, as 250 doctors have already completed the required training to prescribe the product. Roughly two-thirds of those doctors are generalists. Minister of Health Etienne Schneider provided the update in response to a parliamentary question from Martine Hansen, a member of Parliament […]

Read More

Aphria, Wayland face challenge over German marijuana cultivation contracts

Germany’s efforts to get domestic medical cannabis cultivation up and running took another step forward Wednesday, as the German Federal Institute for Drugs and Medical Devices (BfArM) confirmed the winners of nine of the 13 available lots for the first round. Four of the lots – granted to Aphria and Demecan in the preliminary results – were […]

Read More

Brazilian cannabis import authorizations top 1,000 in the first quarter of 2019

Brazilian authorities continued to approve permits to import medical cannabis at an increasing rate through the first quarter of 2019. According to data provided to Marijuana Business Daily, Brazil’s National Sanitary Surveillance Agency (ANVISA) granted 884 new authorizations and 170 renewals during the first quarter of 2019 – more than one-third of all the authorizations that were […]

Read More

European cannabis leader Bedrocan to re-enter Canada, South America

Dutch medical marijuana giant Bedrocan International is poised for an early return to Canada and South America after an arbitration tribunal reduced the duration of a moratorium prohibiting the company from those markets. A legal settlement between Bedrocan and Ontario-based Canopy Growth barred the Dutch company from doing business in Canada until Jan. 1, 2020, and in South […]

Read More

Mexico revokes cannabis guidelines, throwing licenses into doubt

(This story has been updated to include a comment from Aurora Cannabis. – Ed.) Mexico’s main regulatory body for medical cannabis revoked key guidelines used as the basis for issuing dozens of import licenses for low-THC products, putting the status of those permits into question, pending a government review. Toward the end of President Enrique Peña Nieto’s […]

Read More

Insurance-covered cannabis in Germany tops 70 million euros in 2018

Statutory health insurers in Germany covered 73.7 million euros ($83.7 million) worth of medical cannabis products in 2018, according to new data published by German health insurance agency GKV-Spitzenverband. Pharmacies in the country processed 185,370 prescriptions under the statutory program – which covers roughly 90% of the population – during the year. Private prescriptions are […]

Read More

First medical cannabis clinic in United Kingdom opens

Britain’s first dedicated medical marijuana clinic opened in Manchester, setting the groundwork for wider use of MMJ in the country and sparking criticism from some quarters of the medical community. More clinics are expected to open in London and Birmingham later this spring, according to a news release. Only a handful of patients have had access […]

Read More

INCB Report: Certain medical cannabis programs violate international drug control treaties

Only a month after the World Health Organization recommended a less-stringent scheduling of cannabis, the United Nations International Narcotics Control Board (INCB) declared that recreational marijuana programs and several medical programs are “contrary to the international drug control treaties.” The INCB’s 2018 annual report could be a step back for those expecting meaningful reform at an international […]

Read More

UN Commission on Narcotic Drugs delays vote on WHO cannabis recommendations

The United Nations Commission on Narcotic Drugs (CND) will not vote on the World Health Organization’s cannabis recommendations at its March session in Vienna. That news comes after the release of the recommendations, which had been expected in December, was delayed. The proposal, made by the World Health Organization’s Expert Committee on Drug Dependence, could have […]

Read More

Peru lays groundwork for commercial medical cannabis production, sales

More than one year after Peru legalized medical cannabis, the South American country published a regulatory decree providing clarity about how the program will work, including possible cultivation and manufacture of high-THC cannabis by private companies. Details on the breadth of commercial activity that will be allowed remain vague, however. The decree, published Saturday, estimates that […]

Read More